Cytogenetic and molecular study of the PRDX4 gene in a t(X;18)(p22;q23): a cautionary tale

Cancer Genetics and Cytogenetics

Volumn 176, Issue 2, 2007, Pages 131-136

  Gerr, Heidrun D ^a   Nassin, Michele L ^b   Davis, Elizabeth M ^b   Jayathilaka, Nimanthi ^b   Neilly, Mary E ^b   Schlegelberger, Brigitte ^a   Zhang, Yanming ^b   Rowley, Janet D ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIDASE; PEROXIREDOXIN; THIOREDOXIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CHROMOSOME 18; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; ENZYME ACTIVITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE IDENTIFICATION; GENE LOCATION; GENE PROBE; GENE REARRANGEMENT; GENETIC SCREENING; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PRDX4 GENE; PRIORITY JOURNAL;

ADULT; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, X; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CYTOGENETIC ANALYSIS; FEMALE; GENE DUPLICATION; HUMANS; ONCOGENE PROTEINS, FUSION; PEROXIREDOXINS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSLOCATION, GENETIC;

EID: 34447553656     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.03.010     Document Type: Article

References (16)

1. Rowley J.D. The critical role of chromosome translocations in human leukemias. Annu Rev Genet 32 (1998) 495-519
2. Zhang Y., Emmanuel N., Kamboj G., Chen J., Shurafa M., Van Dyke D.L., Wiktor A., and Rowley J.D. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22). Genes Chromosomes Cancer 40 (2004) 365-370
3. Immenschuh S., and Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 7 (2005) 768-777
4. Stock W., Johnson J., Yu D., Bennett D., Sher D., Stone R.M., Kolitz J.E., Powell B.L., Wetzler M., Vardiman J.W., Bloomfield C.D., and Larson R.A. Daunorubicin dose intensification during treatment of adult acute lymphoblastic leukemia (ALL): final results from Cancer and Leukemia Group B Study 19802. [Abstract]. Blood 106 11 (2005) 1833
5. Wood Z.A., Schroder E., Robin Harris J., and Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28 (2003) 32-40
6. Wong C.M., Chun A.C., Kok K.H., Zhou Y., Fung P.C., Kung H.F., Jeang K.T., and Jin D.Y. Characterization of human and mouse peroxiredoxin IV: evidence for inhibition by Prx-IV of epidermal growth factor- and p53-induced reactive oxygen species. Antioxid Redox Signal 2 (2000) 507-518
7. Jin D.Y., Chae H.Z., Rhee S.G., and Jeang K.T. Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation. J Biol Chem (1997) 5;272:30952-61
8. Kohlmann A., Schoch C., Schnittger S., Dugas M., Hiddemann W., Kern W., and Haferlach T. Molecular characterization of acute leukemias by use of microarray technology. Genes Chromosomes Cancer 37 (2003) 396-405
9. Li M., Lin Y.M., Hasegawa S., Shimokawa T., Murata K., Kameyama M., Ishikawa O., Katagiri T., Tsunoda T., Nakamura Y., and Furukawa Y. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 24 (2004) 305-312
10. Jang J.S., Cho H.Y., Lee Y.J., Ha W.S., and Kim H.W. The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 14 (2004) 491-499
11. Schröck E., Veldman T., Padilla-Nash H., Ning Y., Spurbeck J., Jalal S., Shaffer L.G., Papenhausen P., Kozma C., Phelan M.C., Kjeldsen E., Schonberg S.A., O'Brien P., Biesecker L., du Manoir S., and Ried T. Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum Genet 101 (1997) 255-262
12. Rowley J.D., Reshmi S., Carlson K., and Roulston D. Spectral karyotype analysis of T-cell acute leukemia. Blood 93 (1999) 2038-2042
13. Mohr B., Bornhauser M., Thiede C., Schakel U., Schaich M., Illmer T., Pascheberg U., and Ehninger G. Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome. Leukemia 14 (2000) 1031-1038
14. Schoch C., Rieder H., Freund M., Hoelzer D., Riehm H., and Fonatsch C. Twenty-three cases of acute lymphoblastic leukemia with translocation t(4;11)(q21;q23): the implication of additional chromosomal aberrations. Ann Hematol 70 (1995) 195-201
15. Moorman A.V., Raimondi S.C., Pui C.H., Baruchel A., Biondi A., Carroll A.J., Forestier E., Gaynon P.S., Harbott J., Harms D.O., Heerema N., Pieters R., Schrappe M., Silverman L.B., Vilmer E., Harrison C.J., and Ponte di Legno Working Group. No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities. Leukemia 19 (2005) 557-563
16. Johansson B., Moorman A.V., Haas O.A., Watmore A.E., Cheung K.L., Swanton S., Secker-Walker L.M., and European 11q23 Workshop participants. Hematologic malignancies with t(4;11)(q21;q23): a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. Leukemia 12 (1998) 779-787